Dietitians are developing protocols specifically for GLP-1 users, focusing on adequate protein intake, nutrient density, and managing side effects like nausea
It is frequently examined in studies focused on adipose-cell signaling, energy balance, and metabolic efficiency, where researchers investigate how modulation of NNMT activity affects cellular behavior and downstream biological responses
Evidence based on recent studies Initially, cases of intestinal obstruction associated with GLP-1 RAs were reported by the European Medicines Agency (EMA) in 2013 [9], and this safety signal is currently being monitored by the United States (US) FDA
ROS levels were determined using a FACSCanto II flow cytometer (BD Biosciences, San Jose, CA, USA) and the data were analyzed using FlowJo software (V
PlexusDx pairs compounded GLP-1s from licensed 503A pharmacies with optional genetic testing
When used together, MTX and the added drugs can attack joint inflammation from multiple, complementary angles, producing a synergistic effect that is more powerful than either drug alone (Friedman & Cronstein, 2019)